Roman Sherif, Sran Manpreet, Makaryus Amgad N
Internal Medicine, St. Joseph's Regional Medical Center, Paterson, USA.
Internal Medicine, Infinity Hospice Care, Las Vegas, USA.
Cureus. 2022 Jun 22;14(6):e26193. doi: 10.7759/cureus.26193. eCollection 2022 Jun.
Other than acute coronary syndrome (ACS), many clinical conditions are associated with increased cardiac troponin I (cTnI) levels. Conditions such as pulmonary embolism, acute heart failure, myocarditis, sepsis, and renal failure are commonly reported as underlying causes. Analytical interference with the cTnI assay can also lead to falsely elevated troponin I levels. That can happen due to multiple causes such as fibrin clots, heterophile antibodies, microparticles contained in the sample, rheumatoid factor, interference by bilirubin, hemolysis, and elevated alkaline phosphatase activity. Herein, we present the case of a 66-year-old female who presented with pleuritic chest pain and had a cTnI of 35.5 ng/mL post-transfusion of three units of packed red blood cells. The patient had a complete ischemic workup for ACS, including coronary angiography, which was negative for coronary artery disease.
除急性冠状动脉综合征(ACS)外,许多临床情况都与心肌肌钙蛋白I(cTnI)水平升高有关。常见的潜在病因包括肺栓塞、急性心力衰竭、心肌炎、败血症和肾衰竭等情况。对cTnI检测的分析干扰也可能导致肌钙蛋白I水平假性升高。这可能由多种原因引起,如纤维蛋白凝块、嗜异性抗体、样本中含有的微粒、类风湿因子、胆红素干扰、溶血以及碱性磷酸酶活性升高。在此,我们报告一例66岁女性病例,该患者出现胸膜炎性胸痛,在输注三单位浓缩红细胞后cTnI为35.5 ng/mL。患者针对ACS进行了全面的缺血性检查,包括冠状动脉造影,结果显示冠状动脉疾病为阴性。